PROFUSA Shares Outstanding 2022-2025 | PFSA

PROFUSA shares outstanding from 2022 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
PROFUSA Annual Shares Outstanding
(Millions of Shares)
2024 5
2023 5
2022 5
2021 4
PROFUSA Quarterly Shares Outstanding
(Millions of Shares)
2025-09-30 32
2025-06-30 5
2025-03-31 5
2024-12-31 5
2024-09-30 2
2024-06-30 5
2024-03-31 5
2023-12-31 5
2023-09-30 5
2023-06-30 5
2023-03-31 5
2022-12-31 5
2022-09-30 5
2022-06-30 5
2022-03-31 5
2021-12-31
2021-09-30 4
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.001B $0.000B
Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $24.733B 27.19
Tempus AI (TEM) United States $7.677B 0.00
Hims & Hers Health (HIMS) United States $4.429B 38.86
Doximity (DOCS) United States $3.888B 16.84
IRhythm Holdings (IRTC) United States $3.724B 0.00
10x Genomics (TXG) United States $2.973B 0.00
Privia Health (PRVA) United States $2.810B 131.59
Hinge Health (HNGE) United States $2.789B 0.00
Heartflow (HTFL) United States $2.311B 0.00
Omnicell (OMCL) United States $1.564B 43.00
Inspire Medical Systems (INSP) United States $1.555B 20.94
Enovis (ENOV) United States $1.405B 7.40
Butterfly Network (BFLY) United States $1.047B 0.00
Azenta (AZTA) United States $1.023B 41.13
Clover Health Investments (CLOV) United States $1.013B 0.00
Talkspace (TALK) United States $0.864B 103.40
Schrodinger (SDGR) United States $0.839B 0.00
Phreesia (PHR) United States $0.490B 50.38
Fulgent Genetics (FLGT) United States $0.429B 0.00
Standard BioTools (LAB) United States $0.345B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.322B 0.00
CapsoVision (CV) United States $0.311B 0.00
Senseonics Holdings (SENS) United States $0.279B 0.00
Claritev (CTEV) United States $0.269B 0.00
TruBridge (TBRG) United States $0.268B 8.60
Evolent Health (EVH) United States $0.260B 0.00
Carlsmed (CARL) United States $0.239B 0.00
KORU Medical Systems (KRMD) United States $0.196B 0.00
Zepp Health (ZEPP) Netherlands $0.189B 0.00
CareCloud (CCLD) United States $0.115B 8.18
Nyxoah SA (NYXH) Belgium $0.111B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.101B 0.00
American Well (AMWL) United States $0.086B 0.00
Outset Medical (OM) United States $0.077B 0.00
Health Catalyst (HCAT) United States $0.073B 0.00
Pulmonx (LUNG) United States $0.058B 0.00
111 (YI) China $0.057B 0.00
NetraMark Holdings (AINMF) Canada $0.052B 0.00
Precipio (PRPO) United States $0.049B 0.00
HeartBeam (BEAT) United States $0.047B 0.00
Evaxion - (EVAX) Denmark $0.034B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
P3 Health Partners (PIII) United States $0.018B 0.00
EUDA Health Holdings (EUDA) Singapore $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.009B 0.00
Zhongchao (ZCMD) China $0.008B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00